Bob van Gemen
- Virology top 0.5%
- HIV Research and Treatment 13
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 8
- HIV/AIDS Research and Interventions 5
- Internal Medicine top 5%
- Microbiology top 5%
- Epidemiology top 5%
- Mycobacterium research and diagnosis 4
-
- Bacteriophages and microbial interactions 10
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Glycosylation and Glycoproteins Research 4
-
- Blood Coagulation and Thrombosis Mechanisms 4
- Co-authors
- R SchukkinkTim KievitsDianne van StrijpPeter LensSuzanne JurriaansJaap GoudsmitRoy SooknananHenriëtte Adriaanse
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
Bob van Gemen
45 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 98
- Virology 819
- Infectious Diseases 966
- Internal Medicine 81
- Microbiology 124
- Epidemiology 672
Countries citing papers authored by Bob van Gemen
This map shows the geographic impact of Bob van Gemen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob van Gemen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob van Gemen more than expected).
Fields of papers citing papers by Bob van Gemen
This network shows the impact of papers produced by Bob van Gemen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob van Gemen. The network helps show where Bob van Gemen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bob van Gemen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 48 | |
| 2 | 2000 | 164 | |
| 3 | 1999 | 33 | |
| 4 | 1999 | 6 | |
| 5 | 1998 | 32 | |
| 6 | 1998 | 23 | |
| 7 | 1998 | 7 | |
| 8 | 1996 | 31 | |
| 9 | 1996 | 15 | |
| 10 | 1996 | 15 | |
| 11 | Comparison of a nucleic acid amplification system NASBA and agar isolation for detection of pathogenic campylobacters in poultry | 1995 | 4 |
| 12 | 1995 | 33 | |
| 13 | 1995 | 32 | |
| 14 | 1995 | 46 | |
| 15 | 1994 | 41 | |
| 16 | 1993 | 41 | |
| 17 | 1993 | 106 | |
| 18 | 1993 | 62 | |
| 19 | 1991 | 320 | |
| 20 | 1985 | 7 |
About Bob van Gemen
Bob van Gemen is a scholar working on Virology, Infectious Diseases and Internal Medicine, having authored 46 papers that have together received 2.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (13 papers), Bacteriophages and microbial interactions (10 papers), HIV/AIDS drug development and treatment (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), HIV/AIDS Research and Interventions (5 papers), Glycosylation and Glycoproteins Research (4 papers), Mycobacterium research and diagnosis (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). The work is most often cited by research in Virology (819 citations), Infectious Diseases (966 citations) and Internal Medicine (81 citations). Bob van Gemen has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include R Schukkink, Tim Kievits, Dianne van Strijp, Peter Lens, Suzanne Jurriaans, Jaap Goudsmit, Roy Sooknanan, Henriëtte Adriaanse, Rinie van Beuningen and Esther de Rooij.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.